BPK Bespak

RNS Number:2161F
Bespak PLC
05 October 2007



                      ADOPTION OF NEW NAME FOR BESPAK PLC
                                        

With effect from 3rd October, Bespak, a leader in medical devices for inhaled
drug delivery and anaesthesia has changed its name from Bespak plc to Consort
Medical plc.

The Company announced its plan to change its name earlier this year and gained
shareholder approval for the change at its Annual General Meeting at the end of
September.

As the name change applies only to the Company, the familiar Bespak & King
Systems brands will continue to exist in their respective market segments. The
Bespak brand name will be retained in the Inhaled Drug Delivery business segment
which designs and manufactures metered-dose and dry powder inhalers. The King
Systems brand, recognised widely in the US, will remain for the division that
designs and manufactures breathing circuits, masks and laryngeal tubes.

Commenting on the name change, Mark Throdahl, Consort Medical's Chief Executive,
said:

"During recent years the group has grown in both size and focus to become a
leading provider of medical devices. The name 'Consort Medical' conveys our
belief that partnerships with customers, whether they be pharmaceutical
companies or physicians, are critical to our continued success."

ENDS

For further information please contact:

Consort Medical
Mark Throdahl, Chief Executive             Tel: +44 (0)1908 552600
Jonathan Glenn, Group Finance Director

Maitland
Brian Hudspith or Liz Morley               Tel: +44 (0)20 7379 5151


Notes for Editors

About Consort Medical plc

Consort Medical plc is a leader in devices for inhaled drug delivery and
anaesthesia.

The Group develops drug delivery systems for the pharmaceutical industry and
disposable airway management products for critical care settings in hospitals.
Consort Medical's companies develop and manufacture metered dose inhaler valves,
actuators, compliance-aids, dry powder devices, disposable face masks, breathing
circuits and laryngeal tubes.

The Group has facilities in King's Lynn and Milton Keynes in the UK,
Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai, India. Consort
Medical is a public company quoted on the full list of the London Stock Exchange
(LSE: BPK). For more information, please visit www.consortmedical.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
CANIIFEAILLEIID

Bespak (LSE:BPK)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Bespak (LSE:BPK)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025